Product Information
NITROFURANTOIN MCR 50 MG CAP is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.1650 per EA under NDC 62332039031. Its NADAC has been published 132 times since Mar 27, 2024.
FDA first approved this application on Jun 25, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the NITROFURANTOIN market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
50 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332039031
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NITROFURANTOINApproval Type
Generic (ANDA)
FDA Application
ANDA211935FDA Approved
6/25/2021
TE Code
AB
On Market Since
7/1/2021
Pharmacological Classes
Price Statistics
The NADAC for NITROFURANTOIN MCR 50 MG CAP has been published 132 times since Mar 27, 2024, and over the history we have for it it has declined 36.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1650 per EA |
|---|---|
| All-time high | $0.2604 (Apr 10, 2024) |
| All-time low | $0.1396 (May 20, 2026) |
| 52-week high | $0.1866 |
| 52-week low | $0.1396 |
| Median price | $0.1866 |
| Average price | $0.1828 |
| Largest weekly change | +36.3% (Aug 21, 2024) |
| Weeks tracked | 132 |
| Tracking since | Mar 27, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the NITROFURANTOIN market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
NITROFURANTOIN market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nitrofuran Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NITROFURANTOIN MCR 50 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for NITROFURANTOIN MCR 50 MG CAP, manufactured by Alembic Pharmaceuticals Inc., is $0.1650 per EA (NDC 62332039031), effective Sep 30, 2026.
How has the price of NITROFURANTOIN MCR 50 MG CAP changed over time?
Over the history we have for it, the NADAC for NITROFURANTOIN MCR 50 MG CAP has declined 36.6%. It has been tracked across 132 weekly CMS publications since Mar 27, 2024.
What are the highest and lowest recorded NADAC prices for NITROFURANTOIN MCR 50 MG CAP?
Since Mar 27, 2024, the NADAC for NITROFURANTOIN MCR 50 MG CAP has ranged from a low of $0.1396 (May 20, 2026) to a high of $0.2604 (Apr 10, 2024), with a median of $0.1866 per EA.
Are there cheaper alternatives to NITROFURANTOIN MCR 50 MG CAP?
No other NADAC-published product currently shares the active ingredient and strength of NITROFURANTOIN MCR 50 MG CAP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures NITROFURANTOIN MCR 50 MG CAP?
NITROFURANTOIN MCR 50 MG CAP (NDC 62332039031) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.